Published on in Vol 4, No 1 (2015): Jan-Mar

Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial

Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial

Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial

Ashish Atreja 1, MPH,MD;  Sameer Khan 1, BS;  Jason D Rogers 1, BA;  Emamuzo Otobo 1, MD;  Nishant P Patel 1, MD;  Thomas Ullman 2, MD;  Jean Fred Colombel 2, MD;  Shirley Moore 3, RN,PhD;  Bruce E Sands 2, MS,MD;   HealthPROMISE Consortium Group 1*

1 Sinai AppLab, Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, US

2 Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, US

3 Frances Payne Bolton School of Nursing , Case Western Reserve University, Cleveland, OH, US

*these authors contributed equally

Corresponding Author:

  • Ashish Atreja, MPH,MD
  • Sinai AppLab, Division of Gastroenterology
  • Department of Medicine
  • Icahn School of Medicine at Mount Sinai
  • Mailbox 1469
  • 1468 Madison Avenue
  • New York, NY
  • US
  • Phone: 1 212 241 5090
  • Email: ashish.atreja@mssm.edu